The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...
Pfizer (PFE) shares have been inching upward recently, sparking some fresh attention from investors looking to understand ...
On October 27, Nicolas Janvier, Head of North America Equities at Columbia Threadneedle Investments, joined CNBC television ...
Zacks Investment Research on MSN
What Analyst Projections for Key Metrics Reveal About Pfizer (PFE) Q3 Earnings
Wall Street analysts forecast that Pfizer (PFE) will report quarterly earnings of $0.66 per share in its upcoming release, pointing to a year-over-year decline of 37.7%. It is anticipated that ...
In the latest close session, Pfizer (PFE) was down 1.09% at $24.50. This move lagged the S&P 500's daily gain of 0.23%. Meanwhile, the Dow experienced a rise of 0.34%, and the technology-dominated ...
Pfizer (NYSE:PFE) continued losses for seven consecutive sessions, as the stock closed 0.79% lower at $24.54 on Tuesday. In the preceding six sessions, the company lost over 6.4%. Shares of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback